CCL2 and amyotrophic lateral sclerosis: ALS patients were found to have increased levels of monocyte chemotactic protein-1 (MCP-1) and IL-6 in the cerebral spinal fluid (CSF) and sera, while levels of TNF-α were elevated in the blood.